newsfilter
← Latest News
PR Newswire·

Calliditas provides setanaxib patent update

Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the United States Patent and Trademark Office ...